Tuomo Pätsi has been appointed president of the Europe, Middle East and Africa (EMEA) region for Celgene International. Mr. Pätsi will oversee the current portfolio in EMEA as well as international efforts for the company’s pipeline of clinical programs in areas including immunotherapy, epigenetics, ubiquitin ligase targets, cancer metabolism and others. Mr. Pätsi succeeds Alan Colowick, MD, who is taking on another senior strategic position for the company in the U.S.   “It is a very exciting t...